99 results
8-K
EX-99.1
ANVS
Annovis Bio Inc
13 May 24
Annovis Bio Provides Corporate Updates and Announces First Quarter 2024 Financial Results
4:05pm
responsible for PD and AD.
About Annovis Bio, Inc.
Headquartered in Malvern, Pennsylvania, Annovis Bio, Inc. is a clinical-stage, drug platform
424B5
ANVS
Annovis Bio Inc
1 May 24
Prospectus supplement for primary offering
4:50pm
to impaired axonal transport, which is responsible for the communication between and within nerve cells. When that communication is impaired, the immune system … is responsible for appointing the members of our management team, these provisions may frustrate or prevent any attempts by our stockholders to replace
8-K
EX-10.1
pk4wsin9q4js1ka930k
26 Apr 24
Entry into a Material Definitive Agreement
8:14am
8-K
EX-10.2
krwsqw
26 Apr 24
Entry into a Material Definitive Agreement
8:14am
8-K
EX-10.2
pp1tn0vf3 16depsqmo9
21 Mar 24
Entry into a Material Definitive Agreement
5:23pm
424B5
rk7 ml8b2enjwv81a2jc
18 Mar 24
Prospectus supplement for primary offering
10:00pm
424B5
201gnwv0os0 rb31
18 Mar 24
Prospectus supplement for primary offering
8:51pm
8-K
EX-10.2
ldjd01 2jhjl21ob
15 Mar 24
Entry into a Material Definitive Agreement
5:22pm
UPLOAD
qexno
5 Feb 24
Letter from SEC
12:00am